Hi! Simply click below and type your query.
Our experts will reply you very soon.

View Mobile Number
Composition: Ceftazidime 1 gm (also available in 125 mg / 250 mg)
Form: Injection
Class: Third-generation Cephalosporin Antibiotic
Spectrum: Broad-spectrum, effective against Gram-negative and resistant organisms
Efficacy: 97.2% clinical efficacy in pneumonia & URTI
MIC Advantage: Low MIC, 100% sensitivity against Salmonella & Shigella strains
Hepatic Impact: Pharmacokinetics unaffected by hepatic dysfunction
Special Use: Effective in febrile neutropenic patients with hematological malignancies or burns
Comparison: 92% efficacy vs. 88% with Amoxy-Clavulanate combinations
Indications:
Febrile Neutropenic Patients
Pseudomonas Meningitis
Skin, Soft Tissue & Bone Infections
Bacterial Arthritis
Immunocompromised Infections
Septicaemia
Dosage Form: Injectable (administered IV/IM as per physician)
Packaging: Vial
Storage: Below 25°C, protect from moisture and light
Prescription: Required
Specifications
| Country of Origin | India |
| Composition | Ceftazidime 1 Gm |
| Form | Liquid |
| Class | Third-generation Cephalosporin Antibiotic |
| Spectrum | Broad-spectrum, Effective Against Gram-negative And Resistant Organisms |
| MIC Advantage | Low MIC, 100% Sensitivity Against Salmonella & Shigella Strains |
| Hepatic Impact | Pharmacokinetics Unaffected By Hepatic Dysfunction |
| Special Use | Effective In Febrile Neutropenic Patients With Hematological Malignancies Or Burns |
| Storage | Below 25°C, Protect From Moisture And Light |
| Prescription | Required |
| Efficacy | 92% Efficacy Compared To Amoxy-Clavulanate Combination |